Antiarrhythmic Drug
Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug
... I antiarrhythmic drugs inhibit the sodium channel by binding to a drug receptor associated with the ...I antiarrhythmic drug mexiletine to rats induces sodium channel upregulation in isolated ...
5
Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation – a prospective nationwide cohort
... in antiarrhythmic medication was done only in 97 of these patients ...III antiarrhythmic medication was started or the dosage of the drug used was adjusted in 37 ...inadequate antiarrhythmic ...
8
UK 68,798, A Class III Antiarrhythmic Drug with Antifibrillatory Properties
... The antifibrillatory effect of UK-68,798 in the conscious canine model of sudden cardiac death is in accord with results obtained with other class 111 antiarrhythmic drugs such as CK3579[r] ...
12
Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base
... AAD, antiarrhythmic drug; EQ- 5D, EuroQol-5 Dimension; HRQL, health- related quality of life; ICER, incremental cost- effectiveness ratio; QALY, quality- adjusted life- year; RCT, rando[r] ...
8
Amiodarone in Control of Sustained Tachyarrhythmias in Children with Wolff-Parkinson-White Syndrome
... Recent experience with amiodarone hydrochlo- ride, a relatively new antiarrhythmic drug, has shown favorable effects in adult patients with Wolff-Parkinson-White syndrome and recurrent..[r] ...
6
Antiarrhythmic drugs for out of hospital cardiac arrest with refractory ventricular fibrillation
... between antiarrhythmic drug administration and defibrillation success in the amiodarone group was significantly longer than that in the nifekalant group ...of antiarrhythmic drugs (defined as any one ...
6
Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression
... of antiarrhythmic drug therapy was 57% (95% confidence interval [CI] 50–64), multiple procedure success without the use of antiarrhythmic drug therapy was 71% (95% CI 65–77), and the multiple ...
12
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
... novel antiarrhythmic drug that can help patients return to and maintain sinus rhythm, control ventricular response during recurrent episodes of atrial fibrillation, and reduce hospitalizations and ...
11
European Resuscitation Council Guidelines for Resuscitation : 2018 Update – antiarrhythmic drugs for cardiac arrest
... A major consideration for leaving the ERC recommendation largely unchanged is that in our survey of NRCs, 21 out of 24 respondents stated that amiodarone would remain the main antiarrhythmic drug used ...
14
Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?
... other antiarrhythmic drugs (amiodarone, ...III antiarrhythmic drug) has been used after lung resection for cancer in a limited number of studies so far with con- troversial results due to the ...
6
ACC AHA ESC Guidelines Atrial Fibrillation Exec Summary JACC.pdf
... of antiarrhythmic drug ...I antiarrhythmic drugs can unmask this condition ...Out-of-hospital drug termination should be avoided in patients with symptomatic sick sinus syndrome, AV conduction ...
35
Vol 5, No 2 (2013)
... the antiarrhythmic agents, which is a Class 1C antiarrhythmic drug with local anesthetic effects, and direct stabilizing action on myocardial ...gastroretentive drug delivery system was ...
10
Synthesis and Structure-Activity Relationships of a Series of Aporphine Derivatives with Antiarrhythmic Activities and Acute Toxicity
... The antiarrhythmic effects of the derivatives were preliminarily evaluated in a mouse model of ventricular fibrillation (VF), induced by CHCl 3 , and further confirmed in a rat model of arrhythmia, ...
17
Formulation characterization and in vitro evaluation of class 1c antiarrhythmic agent: propafenone into transdermal patches
... transdermal drug active or passive designed affected person thru a permeable reservoir of medication or via the layers of the medication deposited most important disadvantage to shape the fact that the pores and ...
10
ACC AHA HRS 2008 Guidelines for Device-Based Therapy.pdf
... to antiarrhythmic, antibradycardia, atrial fibrillation, bradyarrhythmia, cardiac, CRT, defibrillator, device therapy, devices, dual chamber, heart, heart failure, ICD, implantable defibrillator, device ...
62
The Pharmacology and Clinical Use of Lidocaine and Procainamide
... Both procainamide and lidocaine are useful for acute l y treating cardiac arrhythmias, and procain- amide can be useful in chronic antiarrhythmic regi- mens. Successful[r] ...
12
The Management of Patients with Premature Ventricular Contractions
... At the present time postinfarction patients with fre- quent or advanced grades of PVCs may benefit from antiarrhythmic drugs, partieularly when the PVCs are associated wi[r] ...
5
Mechanisms of sudden cardiac death
... arrhythmic drug therapy has failed to reduce, and in some instances has increased, the incidence of SCD ...their antiarrhythmic potential indirectly by inhibiting or delaying adverse functional and ...
12
Resetting of Cardiac Ventricular Tachycardia Storm with Intravenous Potassium Chloride: A Case Report
... on antiarrhythmic drugs- such as beta blockers, Amiodarone and sodium channel blockers [5] and/or cor- rection of an unbalanced ion level as in hypokalemia [5] ...
8
Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers
... with drug discontinuation, and the remaining four patients needed supportive medical treatment that included intravenous administration of atropine or adrenergic agonist; two of these patients required temporary ...
8